只使用免费官方源：SEC Forms 3/4/5 结构化内部人申报，以及 FINRA Consolidated NMS 场外卖空成交量。 两类数据均保留来源边界，不转写成买卖建议。
SEC 已完成季度 Forms 3/4/5 结构化历史基线 + EDGAR 当前季度 Form 4 增量；个股卡片仅展示当前自然季度的非衍生证券买卖代码 P/S（公开市场或私下交易），成交金额由股数 × 每股价格计算。
官方数据说明| 2026-07-22 2026-07-23 | LWAY Lifeway Foods, Inc. | SMOLYANSKY LUDMILA Other | 卖出（S） | 40,000 | US$29.46 | US$117.84万 | 507,207 | SEC |
| 2026-06-25 2026-06-26 | LWAY Lifeway Foods, Inc. | SMOLYANSKY LUDMILA Other | 卖出（S） | 45,616 | US$29.65 | US$135.25万 | 607,207 | SEC |
| 2026-06-24 2026-06-26 | LWAY Lifeway Foods, Inc. | SMOLYANSKY LUDMILA Other | 卖出（S） | 40,000 | US$30.12 | US$120.48万 | 652,823 | SEC |
| 2026-06-10 2026-06-11 | LWAY Lifeway Foods, Inc. | SMOLYANSKY LUDMILA Other | 卖出（S） | 20,000 | US$24.02 | US$480,400.00 | 692,823 | SEC |
| 2026-05-20 2026-05-21 | BSX BOSTON SCIENTIFIC CORP | LUDWIG EDWARD J Director | 买入（P） | 3,580 | US$56.68 | US$202,914.40 | 25,359 | SEC |
| 2026-05-15 2026-05-19 | LWAY Lifeway Foods, Inc. | SMOLYANSKY LUDMILA Other | 卖出（S） | 20,000 | US$24.64 | US$492,800.00 | 712,823 | SEC |
| 2026-05-12 2026-05-13 | CSTM CONSTELLIUM SE | Piquier Ludovic Officer · SVP Manuf Excellence & CTO | 卖出（S） | 1,000 | US$33.57 | US$33,570.00 | 241,713 | SEC |
| 2026-04-29 2026-05-01 | LUDG LUDWIG ENTERPRISES, INC. | HAUSMAN MARVIN S MD TenPercentOwner | 卖出（S） | 500,000 | US$0.02 | US$10,000.00 | 37,758,000 | SEC |
| 2026-04-21 2026-04-23 | PRLD Prelude Therapeutics Inc | OrbiMed Genesis GP LLC Director,TenPercentOwner | 买入（P） | 1,689,189 | US$4.44 | US$750万 | 11,808,945 | SEC |
| 2026-04-21 2026-04-23 | PRLD Prelude Therapeutics Inc | ORBIMED ADVISORS LLC Director,TenPercentOwner | 买入（P） | 1,689,189 | US$4.44 | US$750万 | 11,808,945 | SEC |
| 2026-04-21 2026-04-23 | PRLD Prelude Therapeutics Inc | OrbiMed Capital GP VI LLC Director,TenPercentOwner | 买入（P） | 1,689,189 | US$4.44 | US$750万 | 11,808,945 | SEC |
| 2026-04-21 2026-04-23 | PRLD Prelude Therapeutics Inc | ORBIMED CAPITAL LLC Director,TenPercentOwner | 买入（P） | 1,689,189 | US$4.44 | US$750万 | 11,808,945 | SEC |
| 2026-04-21 2026-04-23 | PRLD Prelude Therapeutics Inc | OrbiMed Genesis GP LLC Director,TenPercentOwner | 买入（P） | 1,126,126 | US$4.44 | US$500万 | 1,126,126 | SEC |
| 2026-04-21 2026-04-23 | PRLD Prelude Therapeutics Inc | ORBIMED ADVISORS LLC Director,TenPercentOwner | 买入（P） | 1,126,126 | US$4.44 | US$500万 | 1,126,126 | SEC |
| 2026-04-21 2026-04-23 | PRLD Prelude Therapeutics Inc | OrbiMed Capital GP VI LLC Director,TenPercentOwner | 买入（P） | 1,126,126 | US$4.44 | US$500万 | 1,126,126 | SEC |
| 2026-04-21 2026-04-23 | PRLD Prelude Therapeutics Inc | ORBIMED CAPITAL LLC Director,TenPercentOwner | 买入（P） | 1,126,126 | US$4.44 | US$500万 | 1,126,126 | SEC |
| 2026-04-21 2026-04-23 | PRLD Prelude Therapeutics Inc | Bonita David P Director,TenPercentOwner | 买入（P） | 1,689,189 | US$4.44 | US$750万 | 11,808,945 | SEC |
| 2026-04-21 2026-04-23 | PRLD Prelude Therapeutics Inc | Bonita David P Director,TenPercentOwner | 买入（P） | 1,126,126 | US$4.44 | US$500万 | 1,126,126 | SEC |
| 2026-04-20 2026-05-01 | LUDG LUDWIG ENTERPRISES, INC. | HAUSMAN MARVIN S MD TenPercentOwner | 卖出（S） | 1,500,000 | US$0.02 | US$30,000.00 | 38,258,000 | SEC |
| 2026-04-20 2026-04-22 | LWAY Lifeway Foods, Inc. | SMOLYANSKY LUDMILA Other | 卖出（S） | 15,000 | US$26.50 | US$397,500.00 | 732,823 | SEC |
| 代码 | 卖空成交量 | 豁免卖空量 | 场外总成交量 | 卖空量占比 | 报告设施 |
|---|---|---|---|---|---|
| FLUD | 16,460 | 0 | 39,014.7185 | 42.19% | Q |
| LUD | 11,498.202 | 0 | 34,712.0659 | 33.12% | Q, N |